Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Neurocritical Care
Erschienen in: Neurocritical Care 1/2012

01.02.2012 | Review Article

Gastrointestinal Prophylaxis in Neurocritical Care

verfasst von: Clemens M. Schirmer, Joshua Kornbluth, Carl B. Heilman, Anish Bhardwaj

Erschienen in: Neurocritical Care | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study is to review and summarize the relevant literature regarding pharmacologic and non-pharmacologic methods of prophylaxis against gastrointestinal (GI) stress ulceration, and upper gastrointestinal bleeding in critically ill patients. Stress ulcers are a known complication of a variety of critical illnesses. The literature regarding epidemiology and management of stress ulcers and complications thereof, is vast and mostly encompasses patients in medical and surgical intensive care units. This article aims to extrapolate meaningful data for use with a population of critically ill neurologic and neurosurgical patients in the neurological intensive care unit setting. Studies were identified from the cochrane central register of controlled trials and NLM PUBMED for english articles dealing with an adult population. We also scanned bibliographies of relevant studies. The results show that H2A, sucralfate, and PPI all reduce the incidence of UGIB in neurocritically ill patients, but H2A blockers may cause encephalopathy and interact with anticonvulsant drugs, and have been associated with higher rates of nosocomial pneumonias, but causation remains unproven and controversial. For these reasons, we advocate against routine use of H2A for GI prophylaxis in neurocritical patients. There is a paucity of high-level evidence studies that apply to the neurocritical care population. From this study, it is concluded that stress ulcer prophylaxis among critically ill neurologic and neurosurgical patients is important in preventing ulcer-related GI hemorrhage that contributes to both morbidity and mortality. Further, prospective trials are needed to elucidate which methods of prophylaxis are most appropriate and efficacious for specific illnesses in this population.
Literatur
1.
Chan KH, Mann KS, Lai EC, Ngan J, Tuen H, Yue CP. Factors influencing the development of gastrointestinal complications after neurosurgery: results of multivariate analysis. Neurosurgery. 1989;25(3):378–82.PubMedCrossRef
2.
Leramo OB, Tator CH, Hudson AR. Massive gastroduodenal hemorrhage and perforation in acute spinal cord injury. Surg Neurol. 1982;17(3):186–90.PubMedCrossRef
3.
Misra UK, Kalita J, Pandey S, Mandal SK. Predictors of gastrointestinal bleeding in acute intracerebral haemorrhage. J Neurol Sci. 2003;208(1–2):25–9.PubMedCrossRef
4.
Misra UK, Kalita J, Pandey S, Mandal SK, Srivastava M. A randomized placebo controlled trial of ranitidine versus sucralfate in patients with spontaneous intracerebral hemorrhage for prevention of gastric hemorrhage. J Neurol Sci. 2005;239(1):5–10.PubMedCrossRef
5.
O’Donnell MJ, Kapral MK, Fang J, Saposnik G, Eikelboom JW, Oczkowski W, Silva J, Gould L, D’Uva C, Silver FL. Gastrointestinal bleeding after acute ischemic stroke. Neurology. 2008;71(9):650–5.PubMedCrossRef
6.
Schaller BJ, Graf R, Jacobs AH. Pathophysiological changes of the gastrointestinal tract in ischemic stroke. Am J Gastroenterol. 2006;101(7):1655–65.PubMedCrossRef
7.
Cook D, Heyland D, Griffith L, Cook R, Marshall J, Pagliarello J. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian critical care trials group. Crit Care Med. 1999;27(12):2812–7.PubMedCrossRef
8.
Yang YX, Lewis JD. Prevention and treatment of stress ulcers in critically ill patients. Semin Gastrointest Dis. 2003;14(1):11–9.PubMed
9.
Cushing H. Peptic ulcer and the interbrain. Surg Obst. 1932;55:1–34.
10.
Rokitansky C. Handbuch der pathologischen Anatomie, vol 3. Braunmueller und Seidel: Wien;1842 p. 197.
11.
Fennerty MB. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Crit Care Med. 2002;30(6 Suppl):S351–5.PubMedCrossRef
12.
Idjadi F, Robbins R, Stahl WM, Essiet G. Prospective study of gastric secretion in stressed patients with intracranial injury. J Trauma. 1971;11(8):681–8.PubMedCrossRef
13.
Quenot JP, Thiery N, Barbar S. When should stress ulcer prophylaxis be used in the ICU? Curr Opin Crit Care. 2009;15(2):139–43.PubMedCrossRef
14.
Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol. 2008;64(10):935–51.PubMedCrossRef
15.
Kamada T, Fusamoto H, Kawano S, Noguchi M, Hiramatsu K. Gastrointestinal bleeding following head injury: a clinical study of 433 cases. J Trauma. 1977;17(1):44–7.PubMedCrossRef
16.
Mutlu GM, Mutlu EA, Factor P. GI complications in patients receiving mechanical ventilation. Chest. 2001;119(4):1222–41.PubMedCrossRef
17.
Cook DJ, Reeve BK, Guyatt GH, Heyland DK, Griffith LE, Buckingham L, Tryba M. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA. 1996;275(4):308–14.PubMedCrossRef
18.
Cook DJ, Griffith LE, Walter SD, Guyatt GH, Meade MO, Heyland DK, Kirby A, Tryba M. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care. 2001;5(6):368–75.PubMedCrossRef
19.
Sesler JM. Stress-related mucosal disease in the intensive care unit: an update on prophylaxis. AACN Adv Crit Care. 2007;18(2):119–26. quiz 127-8.PubMedCrossRef
20.
Karch SB. Upper gastrointestinal bleeding as a complication of intracranial disease. J Neurosurg. 1972;37(1):27–9.PubMedCrossRef
21.
Chan KH, Mann KS. Failure of cimetidine prophylaxis in neurosurgery. Aust N Z J Surg. 1989;59(2):133–6.PubMedCrossRef
22.
Chan KH, Lai EC, Tuen H, Ngan JH, Mok F, Fan YW, Fung CF, Yu WC. Prospective double-blind placebo-controlled randomized trial on the use of ranitidine in preventing postoperative gastroduodenal complications in high-risk neurosurgical patients. J Neurosurg. 1995;82(3):413–7.PubMedCrossRef
23.
Gordon MJ, Skillman JJ, Zervas NT, Silen W. Divergent nature of gastric mucosal permeability and gastric acid secretion in sick patients with general surgical and neurosurgical disease. Ann Surg. 1973;178(3):285–94.PubMedCrossRef
24.
Reusser P, Gyr K, Scheidegger D, Buchmann B, Buser M, Zimmerli W. Prospective endoscopic study of stress erosions and ulcers in critically ill neurosurgical patients: current incidence and effect of acid-reducing prophylaxis. Crit Care Med. 1990;18(3):270–4.PubMedCrossRef
25.
Bowen JC, Fleming WH, Thompson JC. Increased gastrin release following penetrating central nervous system injury. Surgery. 1974;75(5):720–4.PubMed
26.
Gudeman SK, Wheeler CB, Miller JD, Halloran LG, Becker DP. Gastric secretory and mucosal injury response to severe head trauma. Neurosurgery. 1983;12(2):175–9.PubMedCrossRef
27.
Halloran LG, Zfass AM, Gayle WE, Wheeler CB, Miller JD. Prevention of acute gastrointestinal complications after severe head injury: a controlled trial of cimetidine prophylaxis. Am J Surg. 1980;139(1):44–8.PubMedCrossRef
28.
Hatton J, Lu WY, Rhoney DH, Tibbs PA, Dempsey RJ, Young B. A step-wise protocol for stress ulcer prophylaxis in the neurosurgical intensive care unit. Surg Neurol. 1996;46(5):493–9.PubMedCrossRef
29.
Burgess P, Larson GM, Davidson P, Brown J, Metz CA. Effect of ranitidine on intragastric pH and stress-related upper gastrointestinal bleeding in patients with severe head injury. Dig Dis Sci. 1995;40(3):645–50.PubMedCrossRef
30.
Metz CA, Livingston DH, Smith JS, Larson GM, Wilson TH. Impact of multiple risk factors and ranitidine prophylaxis on the development of stress-related upper gastrointestinal bleeding: a prospective, multicenter, double-blind, randomized trial. The ranitidine head injury study group. Crit Care Med. 1993;21(12):1844–9.PubMedCrossRef
31.
Norton L, Greer J, Eiseman B. Gastric secretory response to head injury. Arch Surg. 1970;101(2):200–4.PubMedCrossRef
32.
33.
Brown TH, Davidson PF, Larson GM. Acute gastritis occurring within 24 hours of severe head injury. Gastrointest Endosc. 1989;35(1):37–40.PubMedCrossRef
34.
Li ZM, Wang LX, Jiang LC, Zhu JX, Geng FY, Qiang F. Relationship between plasma cortisol levels and stress ulcer following acute and severe head injury. Med Princ Pract. 2010;19(1):17–21.PubMedCrossRef
35.
Epstein N, Hood DC, Ransohoff J. Gastrointestinal bleeding in patients with spinal cord trauma. Effects of steroids, cimetidine, and mini-dose heparin. J Neurosurg. 1981;54(1):16–20.PubMedCrossRef
36.
Gore RM, Mintzer RA, Calenoff L. Gastrointestinal complications of spinal cord injury. Spine (Phila Pa 1976). 1981;6(6):538–44.CrossRef
37.
Kiwerski J. Bleeding from the alimentary canal during the management of spinal cord injury patients. Paraplegia. 1986;24(2):92–6.PubMedCrossRef
38.
Kuric J, Lucas CE, Ledgerwood AM, Kiraly A, Salciccioli GG, Sugawa C. Nutritional support: a prophylaxis against stress bleeding after spinal cord injury. Paraplegia. 1989;27(2):140–5.PubMedCrossRef
39.
Walters K, Silver JR. Gastrointestinal bleeding in patients with acute spinal injuries. Int Rehabil Med. 1986;8(1):44–7.PubMed
40.
El Masri WE, Cochrane P, Silver JR. Gastrointestinal bleeding in patients with acute spinal injuries. Injury. 1982;14(2):162–7.PubMedCrossRef
41.
Albert TJ, Levine MJ, Balderston RA, Cotler JM. Gastrointestinal complications in spinal cord injury. Spine (Phila Pa 1976). 1991;16(10 Suppl):S522–5.CrossRef
42.
Soderstrom CA, Ducker TB. Increased susceptibility of patients with cervical cord lesions to peptic gastrointestinal complications. J Trauma. 1985;25(11):1030–8.PubMed
43.
Filaretova L, Morozova O, Bagaeva T, Podvigina T. From gastroprotective to proulcerogenic action of glucocorticoids on the gastric mucosa. J Physiol Pharmacol. 2009;60(Suppl 7):79–86.PubMed
44.
Westwell S. Implementing a ventilator care bundle in an adult intensive care unit. Nurs Crit Care. 2008;13(4):203–7.PubMedCrossRef
45.
Davenport RJ, Dennis MS, Warlow CP. Gastrointestinal hemorrhage after acute stroke. Stroke. 1996;27(3):421–4.PubMedCrossRef
46.
Wijdicks EF, Fulgham JR, Batts KP. Gastrointestinal bleeding in stroke. Stroke. 1994;25(11):2146–8.PubMedCrossRef
47.
Hamidon BB, Raymond AA. The risk factors of gastrointestinal bleeding in acute ischaemic stroke. Med J Malaysia. 2006;61(3):288–91.PubMed
48.
Tsuchiya J, Ito Y, Hino T, Ohashi H, Kunieda T, Sakata K. Stress ulcer accompanying subarachnoid hemorrhage—a new rat model. Jpn J Surg. 1983;13(4):373–80.PubMedCrossRef
49.
Sakata K, Nonomura O, Ito Y, Tsuchiya J, Ohashi H. Neurogenic stress gastric ulceration—an experimental study in rats. No Shinkei Geka. 1987;15(10):1057–63.PubMed
50.
Iberti TJ. Hemodynamic effects of H2-receptor antagonists. DICP. 1990;24(11 Supp):S35–7.PubMed
51.
Ostro MJ. Pharmacodynamics and pharmacokinetics of parenteral histamine (H2)-receptor antagonists. Am J Med. 1987;83(6A):15–22.PubMedCrossRef
52.
Yue CP, Mann KS, Chan KH. Severe thrombocytopenia due to combined cimetidine and phenytoin therapy. Neurosurgery. 1987;20(6):963–5.PubMedCrossRef
53.
Messori A, Trippoli S, Vaiani M, Gorini M, Corrado A. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ. 2000;321(7269):1103–6.PubMedCrossRef
54.
Kimelblatt BJ, Cerra FB, Calleri G, Berg MJ, McMillen MA, Schentag JJ. Dose and serum concentration relationships in cimetidine-associated mental confusion. Gastroenterology. 1980;78(4):791–5.PubMed
55.
Lacroix J, Infante-Rivard C, Jenicek M, Gauthier M. Prophylaxis of upper gastrointestinal bleeding in intensive care units: a meta-analysis. Crit Care Med. 1989;17(9):862–9.PubMedCrossRef
56.
Tryba M. Sucralfate versus antacids or H2-antagonists for stress ulcer prophylaxis: a meta-analysis on efficacy and pneumonia rate. Crit Care Med. 1991;19(7):942–9.PubMedCrossRef
57.
Martin LF, Booth FV, Karlstadt RG, Silverstein JH, Jacobs DM, Hampsey J, Bowman SC, D’Ambrosio CA, Rockhold FW. Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med. 1993;21(1):19–30.PubMedCrossRef
58.
Glavin GB. Role of the central nervous system in stress ulcers. Compr Ther. 1991;17(4):3–5.PubMed
59.
Lu WY, Rhoney DH, Boling WB, Johnson JD, Smith TC. A review of stress ulcer prophylaxis in the neurosurgical intensive care unit. Neurosurgery. 1997;41(2):416–25. discussion 425-6.PubMedCrossRef
60.
Yang YX, Metz DC. Safety of proton pump inhibitor exposure. Gastroenterology. 2010;139(4):1115–27.PubMedCrossRef
61.
Gilard M, Arnaud B, Cornily JC, Le Gal G, Lacut K, Le Calvez G, Mansourati J, Mottier D, Abgrall JF, Boschat J. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (omeprazole clopidogrel aspirin) study. J Am Coll Cardiol. 2008;51(3):256–60.PubMedCrossRef
62.
Siriswangvat S, Sansanayudh N, Nathisuwan S, Panomvana D. Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel. Circ J. 2010;74(10):2187–92.PubMedCrossRef
63.
Lin PC, Chang CH, Hsu PI, Tseng PL, Huang YB. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Crit Care Med. 2010;38(4):1197–205.PubMedCrossRef
64.
Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess. 2007;11(51):1–164, iii–iv.
65.
Morrissey JF, Barreras RF. Drug therapy. Antacid therapy. N Engl J Med. 1974;290(10):550–4.PubMedCrossRef
66.
Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, Winton TL, Rutledge F, Todd TJ, Roy P, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian critical care trials group. N Engl J Med. 1994;330(6):377–81.PubMedCrossRef
67.
Slomiany BL, Piotrowski J, Okazaki K, Grzelinska E, Slomiany A. Nature of the enhancement of the protective qualities of gastric mucus by sucralfate. Digestion. 1989;44(4):222–31.PubMedCrossRef
68.
Tryba M. Stress bleeding prophylaxis with sucralfate. Pathophysiologic basis and clinical use. Scand J Gastroenterol Suppl. 1990;173:22–33.PubMedCrossRef
69.
Chen BW, Hiu WM, Lam SK, Cho CH, Ng MM, Luk CT. Effect of sucralfate on gastric mucosal blood flow in rats. Gut. 1989;30(11):1544–51.PubMedCrossRef
70.
71.
Eddleston JM, Vohra A, Scott P, Tooth JA, Pearson RC, McCloy RF, Morton AK, Doran BH. A comparison of the frequency of stress ulceration and secondary pneumonia in sucralfate-or ranitidine-treated intensive care unit patients. Crit Care Med. 1991;19(12):1491–6.PubMedCrossRef
72.
Tryba M. Prophylaxis of stress ulcer bleeding. A meta-analysis. J Clin Gastroenterol. 1991;13(Suppl 2):S44–55.PubMed
73.
Zinner MJ, Rypins EB, Martin LR, Jonasson O, Hoover EL, Swab EA, Fakouhi TD. Misoprostol versus antacid titration for preventing stress ulcers in postoperative surgical ICU patients. Ann Surg. 1989;210(5):590–5.PubMedCrossRef
74.
Goldberg AB, Wing DA. Induction of labor: the misoprostol controversy. J Midwifery Womens Health. 2003;48(4):244–8.PubMedCrossRef
75.
Maury E, Tankovic J, Ebel A, Offenstadt G. An observational study of upper gastrointestinal bleeding in intensive care units: is Helicobacter pylori the culprit? Crit Care Med. 2005;33(7):1513–8.PubMedCrossRef
76.
Ali T, Harty RF. Stress-induced ulcer bleeding in critically ill patients. Gastroenterol Clin North Am. 2009;38(2):245–65.PubMedCrossRef
77.
Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, Peters S, Rutledge F, Griffith L, McLellan A, Wood G, Kirby A. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian critical care trials group. N Engl J Med. 1998;338(12):791–7.PubMedCrossRef
78.
Conrad SA, Gabrielli A, Margolis B, Quartin A, Hata JS, Frank WO, Bagin RG, Rock JA, Hepburn B, Laine L. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med. 2005;33(4):760–5.PubMedCrossRef
79.
Brophy GM, Brackbill ML, Bidwell KL, Brophy DF. Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients. Neurocrit Care. 2010;13(2):176–81.PubMedCrossRef
80.
Daley RJ, Rebuck JA, Welage LS, Rogers FB. Prevention of stress ulceration: current trends in critical care. Crit Care Med. 2004;32(10):2008–13.PubMedCrossRef
81.
Barletta JF, Erstad BL, Fortune JB. Stress ulcer prophylaxis in trauma patients. Crit Care. 2002;6(6):526–30.PubMedCrossRef
82.
Pimentel M, Roberts DE, Bernstein CN, Hoppensack M, Duerksen DR. Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis. Am J Gastroenterol. 2000;95(10):2801–6.PubMedCrossRef
83.
Kantorova I, Svoboda P, Scheer P, Doubek J, Rehorkova D, Bosakova H, Ochmann J. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology. 2004;51(57):757–61.PubMed
84.
Faisy C, Guerot E, Diehl JL, Iftimovici E, Fagon JY. Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxis. Intensive Care Med. 2003;29(8):1306–13.PubMedCrossRef
85.
Pingleton SK, Hinthorn DR, Liu C. Enteral nutrition in patients receiving mechanical ventilation. Multiple sources of tracheal colonization include the stomach. Am J Med. 1980;80(5):827–32.CrossRef
86.
Garcia Rodriguez LA, Barreales Tolosa L. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology. 2007;132(2):498–506.PubMedCrossRef
87.
Lanas A, Garcia-Rodriguez LA, Arroyo MT, Gomollon F, Feu F, Gonzalez-Perez A, Zapata E, Bastida G, Rodrigo L, Santolaria S, Guell M, de Argila CM, Quintero E, Borda F, Pique JM. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut. 2006;55(12):1731–8.PubMedCrossRef
88.
Fisher L, Fisher A, Pavli P, Davis M. Perioperative acute upper gastrointestinal haemorrhage in older patients with hip fracture: incidence, risk factors and prevention. Aliment Pharmacol Ther. 2007;25(3):297–308.PubMedCrossRef
89.
ASHP therapeutic guidelines on stress ulcer prophylaxis. ASHP commission on therapeutics and approved by the ASHP board of directors on November 14, 1998. Am J Health Syst Pharm, 1999;56(4):p. 347–79.
90.
Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296(24):2947–53.PubMedCrossRef
Metadaten
Titel
Gastrointestinal Prophylaxis in Neurocritical Care
verfasst von
Clemens M. Schirmer
Joshua Kornbluth
Carl B. Heilman
Anish Bhardwaj
Publikationsdatum
01.02.2012
Verlag
Humana Press Inc
Erschienen in
Neurocritical Care / Ausgabe 1/2012
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-011-9580-1

Weitere Artikel der Ausgabe 1/2012

Neurocritical Care 1/2012 Zur Ausgabe

Original Article

Autonomic Effects of Intraventricular Extension in Intracerebral Hemorrhage

Practical Pearl

Intracranial Aneurysm with Concomitant Rupture of an Undiagnosed Visceral Artery Aneurysm

Practical Pearl

Wolf in Sheep’s Clothing: Acute Chloroma Disguised as a Subdural Hematoma

Original Article

Frequency and Timing of Nonconvulsive Status Epilepticus in Comatose Post-Cardiac Arrest Subjects Treated with Hypothermia

Neuroimage

Ongoing Abdominal Status Myoclonus in Postanoxic Coma

Review

Neurocritical Care Nursing Research Priorities

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise